[1] |
Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association.
Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition)
[J]. China Oncology, 2024, 34(8): 785-805.
|
[2] |
LIU Shuai, ZHANG Kai, ZHANG Xiaoqing, LUAN Wei.
An exploratory study on the perioperative treatment of locally advanced gastric cancer with combination of penpulimab, anlotinib and chemotherapy
[J]. China Oncology, 2024, 34(7): 659-668.
|
[3] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
[4] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[5] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[6] |
QIAN Bin, CHEN Haiquan.
Important progress in surgical treatment of lung cancer in 2023
[J]. China Oncology, 2024, 34(4): 335-339.
|
[7] |
FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao.
Progress in treatment of gynecological cancer in 2023
[J]. China Oncology, 2024, 34(4): 340-360.
|
[8] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[9] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[10] |
WANG Xuefei, ZHOU Peng, TANG Zhaoqing.
New progress and development trend of surgical treatment for gastric cancer
[J]. China Oncology, 2024, 34(3): 250-258.
|
[11] |
ZHANG Qi, XIU Bingqiu, WU Jiong.
Progress of important clinical research of breast cancer in China in 2023
[J]. China Oncology, 2024, 34(2): 135-142.
|
[12] |
ZHANG Siyuan, JIANG Zefei.
Important research progress in clinical practice for advanced breast cancer in 2023
[J]. China Oncology, 2024, 34(2): 143-150.
|
[13] |
ZHANG Siwei, MA Ding, JIANG Yizhou, SHAO Zhimin.
“Subtype-precise” therapy leads diagnostic and therapeutic innovations: a new pattern for precision treatment of breast cancer
[J]. China Oncology, 2024, 34(11): 1045-1052.
|
[14] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|
[15] |
JIANG Lili, MA Yan, ZHANG Tiantian, HUANG Shan.
Clinical analysis of 21 cases of primary Ewing sarcoma of the thoracic wall
[J]. China Oncology, 2024, 34(1): 74-81.
|